LOK Corporation Announces its Latest Partnership with PROTXX
Publishing date: 2 October 2020
LOK Corporation is thrilled to announce that we now represent PROTXX, a pioneering provider of wearable patient management solutions. We look forward to establishing strong distribution channels for PROTXX throughout the world. “We believe that PROTXX will be a game-changer in both sports medicine and neurology, two growing medical segments that we strongly believe in and that will be part of the core of our business in 2021.” added Daniel Cloutier, CEO of LOK Corporation.
The PROTXX precision healthcare platform integrates wearable sensor and machine learning innovations to replace bulky and expensive clinical equipment and time-consuming testing procedures for a variety of neurodegenerative medical conditions in which patients suffer from impairments to multiple physiological systems. PROTXX solves the difficult problem of identifying and quantifying these multiple different impairments, disrupting diagnosis and treatment with easy-to-use, low-cost, in-clinic and remote patient assessments.
Current clinical neurology, rehabilitation medicine, and sports medicine applications of the PROTXX platform include stroke, concussions, elderly frailty, Parkinson’s disease, multiple sclerosis, peripheral neuropathies, and neurosurgeries. These medical conditions together impact 100’s of millions of patients worldwide, and each one on its own generates annual healthcare costs between 30 billion and 70 billion dollars in the U.S. alone.
John Ralston, PROTXX CEO and founder, commented: “LOK’s global reach in medical product distribution makes them the ideal partner to maximize the economic impact of PROTXX innovations. Of the more than $3 trillion in annual healthcare costs generated by neurodegenerative conditions worldwide, 25% or more arise from inefficiencies that can be reduced or eliminated using wearable devices and remote patient monitoring solutions such as those developed by PROTXX.”
PROTXX customers and partners in Canada, the U.S., the U.K., and Japan are already helping healthcare payers rein in costs, providers improve quality of care, and consumers gain greater access to higher quality care and improved outcomes. PROTXX innovations have been recognized with numerous industrial, academic, and government awards.